-
Increased incidence of Mycoplasma pneumoniae infections and hospital admissions in the Netherlands, November to December 2023
- Dita C Bolluyt1 , Sjoerd M Euser2,* , Dennis Souverein2,* , Annemarie MC van Rossum3 , Jayant Kalpoe2 , Mireille van Westreenen4 , Marco Goeijenbier5,6 , Dominic Snijders7 , Dirk Eggink8 , Femke Jongenotter8 , Steven FL van Lelyveld1,* , Marlies A van Houten9,*
-
View Affiliations Hide AffiliationsAffiliations: 1 Department of Internal Medicine, Spaarne Gasthuis, Haarlem/Hoofddorp, the Netherlands 2 Regional Public Health Laboratory Kennemerland, Haarlem, The Netherlands 3 Department of Paediatrics, Erasmus MC University Medical Centre, Rotterdam, the Netherlands 4 Department of Medical Microbiology, Erasmus MC University Medical centre, Rotterdam, the Netherlands 5 Department of Intensive Care Medicine, Spaarne Gasthuis, Haarlem/Hoofddorp, the Netherlands 6 Department of Intensive Care Medicine, Erasmus MC University Medical Centre, Rotterdam, the Netherlands 7 Department of Pulmonary Medicine, Spaarne Gasthuis, Haarlem/Hoofddorp, the Netherlands 8 Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands 9 Department of Paediatrics, Spaarne Gasthuis, Haarlem/Hoofddorp, The Netherlands * These authors contributed equally to this work and share authorship.Steven van Lelyvelds.van.lelyveld spaarnegasthuis.nl
-
View Citation Hide Citation
Citation style for this article: Bolluyt Dita C, Euser Sjoerd M, Souverein Dennis, van Rossum Annemarie MC, Kalpoe Jayant, van Westreenen Mireille, Goeijenbier Marco, Snijders Dominic, Eggink Dirk, Jongenotter Femke, van Lelyveld Steven FL, van Houten Marlies A. Increased incidence of Mycoplasma pneumoniae infections and hospital admissions in the Netherlands, November to December 2023. Euro Surveill. 2024;29(4):pii=2300724. https://doi.org/10.2807/1560-7917.ES.2024.29.4.2300724 Received: 21 Dec 2023; Accepted: 24 Jan 2024
- Previous Article
- Table of Contents
- Next Article
Abstract
Mycoplasma pneumoniae is an important cause of pneumonia and extra-pulmonary manifestations. We observed a rise in admissions due to M. pneumoniae infections starting October 2023 in a regional hospital in the Netherlands and an increased incidence in national surveillance data. The incidence in the Netherlands has not been that high since 2011. The patients had a lower median age compared with 2019 and 2020 (28 vs 40 years). M. pneumoniae should be considered in patients with respiratory symptoms, especially children.
Article metrics loading...
Full text loading...
References
-
de Groot RCA, Meyer Sauteur PM, Unger WWJ, van Rossum AMC. Things that could be Mycoplasma pneumoniae. J Infect. 2017;74(Suppl 1):S95-100. https://doi.org/10.1016/S0163-4453(17)30198-6 PMID: 28646969
-
Søndergaard MJ, Friis MB, Hansen DS, Jørgensen IM. Clinical manifestations in infants and children with Mycoplasma pneumoniae infection. PLoS One. 2018;13(4):e0195288. https://doi.org/10.1371/journal.pone.0195288 PMID: 29698412
-
Waites KB, Talkington DF. Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev. 2004;17(4):697-728. https://doi.org/10.1128/CMR.17.4.697-728.2004 PMID: 15489344
-
Meyer Sauteur PM, Beeton ML, Uldum SA, Bossuyt N, Vermeulen M, Loens K, et al. Mycoplasma pneumoniae detections before and during the COVID-19 pandemic: results of a global survey, 2017 to 2021. Euro Surveill. 2022;27(19):2100746. https://doi.org/10.2807/1560-7917.ES.2022.27.19.2100746 PMID: 35551702
-
Fourie E, Bording ES, Euser SM, Badoux P, Haverkort ME, van Houten MA. Nasal discharge: A unique enhanced alternative for the detection of respiratory pathogens in adults. J Med Virol. 2023;95(8):e29047. https://doi.org/10.1002/jmv.29047 PMID: 37621163
-
Rijksinstituut voor Volksgezondheid en Milieu (RIVM). Virologische weekstaten. [Weekly virological statistics]. Bilthoven: RIVM. [Accessed: 15 December 2023]. Dutch. Available from: https://www.rivm.nl/virologische-weekstaten
-
Rijksinstituut voor Volksgezondheid en Milieu (RIVM). Infectieradar. [Infection radar]. Bilthoven: RIVM. [Accessed: 19 December 2023]. Dutch. Available from: https://www.infectieradar.nl/about
-
PathoFinder. PathoFinder B.V.; 2021, Available from: https://www.pathofinder.com/2smart-products/pf2600-2s
-
Reukers D, van Asten L, Brandsema P, Dijkstra F, Hendriksen J, van der Hoek W, et al. Annual report. Surveillance of influenza and other respiratory infections in the Netherlands: winter 2019/2020. Bilthoven: Rijksinstituut voor Volksgezondheid en Milieu; 2021. Available from: https://www.rivm.nl/bibliotheek/rapporten/2020-0177.pdf
-
Brandsema P, Dijkstra F, Euser S, van Gageldonk-Lafeber A, de Lange M, Meijer A, et al. Jaarrapportage surveillance respiratoire infectieziekten 2011. [Annual report surveillance respiratory infectious diseases 2011]. Bilthoven: Rijksinstituut voor Volksgezondheid en Milieu; 2012. Dutch. Available from: https://www.rivm.nl/bibliotheek/rapporten/201041001.html
-
Meyer Sauteur PM, Beeton ML, Pereyre S, Bébéar C, Gardette M, Hénin N, et al. Mycoplasma pneumoniae: delayed re-emergence after COVID-19 pandemic restrictions. Lancet Microbe. 2023;S2666-5247(23)00344-0. https://doi.org/10.1016/S2666-5247(23)00344-0 PMID: 38008103
-
Nordholm AC, Søborg B, Jokelainen P, Lauenborg Møller K, Flink Sørensen L, Grove Krause T, et al. Mycoplasma pneumoniae epidemic in Denmark, October to December, 2023. Euro Surveill. 2024;29(2):2300707. https://doi.org/10.2807/1560-7917.ES.2024.29.2.2300707 PMID: 38214084
-
Omori R, Nakata Y, Tessmer HL, Suzuki S, Shibayama K. The determinant of periodicity in Mycoplasma pneumoniae incidence: an insight from mathematical modelling. Sci Rep. 2015;5(1):14473. https://doi.org/10.1038/srep14473 PMID: 26412506
-
Oster Y, Michael-Gayego A, Rivkin M, Levinson L, Wolf DG, Nir-Paz R. Decreased prevalence rate of respiratory pathogens in hospitalized patients during the COVID-19 pandemic: possible role for public health containment measures? Clin Microbiol Infect. 2020;27(5):811-2. https://doi.org/10.1016/j.cmi.2020.12.007 PMID: 33352303
-
Cohen R, Levy C, Rybak A, Angoulvant F, Ouldali N, Grimprel E. Immune debt: Recrudescence of disease and confirmation of a contested concept. Infect Dis Now. 2023;53(2):104638. https://doi.org/10.1016/j.idnow.2022.12.003 PMID: 36535583
-
Reukers D, van Asten L, Hooiveld M, Jongenotter F, de Lange M, Teirlinck A, et al. Surveillance van acute luchtweginfecties in Nederland: winter 2022/2023. [Surveillance of acute respiratory infections in the Netherlands: winter 2022/2023. SARS-CoV-2, influenza virus, RSV and other respiratory viruses.] Bilthoven: Rijksinstituut voor Volksgezondheid en Milieu; 2023. Dutch. Available from: https://www.rivm.nl/bibliotheek/rapporten/2023-0378.pdf
-
European Centre for Disease Prevention and Control (ECDC). Acute respiratory infections in the EU/EEA: epidemiological update and current public health recommendations 2023. Stockholm: ECDC; 2023. Available from: https://www.ecdc.europa.eu/en/news-events/acute-respiratory-infections-eueea-epidemiological-update-and-current-public-health
-
World Health Organization (WHO). Upsurge of respiratory illnesses among children-Northern China. Geneva: WHO; 2023. Available from: https://www.who.int/emergencies/disease-outbreak-news/item/2023-DON494
-
Wiersinga WJ, Bonten MJ, Boersma WG, Jonkers RE, Aleva RM, Kullberg BJ, et al. Management of community-acquired pneumonia in adults: 2016 guideline update from the Dutch Working Party on Antibiotic Policy (SWAB) and Dutch Association of Chest Physicians (NVALT). Neth J Med. 2018;76(1):4-13. PMID: 29380739
-
Pereyre S, Goret J, Bébéar C. Mycoplasma pneumoniae: current knowledge on macrolide resistance and treatment. Front Microbiol. 2016;7:974. https://doi.org/10.3389/fmicb.2016.00974 PMID: 27446015
-
Schroeder MR, Stephens DS. Macrolide resistance in Streptococcus pneumoniae. Front Cell Infect Microbiol. 2016;6:98. https://doi.org/10.3389/fcimb.2016.00098 PMID: 27709102
-
Smith MJ. Macrolides and pediatric community-acquired pneumonia-time for a paradigm shift? JAMA Pediatr. 2017;171(12):1147-8. https://doi.org/10.1001/jamapediatrics.2017.3828 PMID: 29084314
-
Spuesens EB, Fraaij PL, Visser EG, Hoogenboezem T, Hop WC, van Adrichem LN, et al. Carriage of Mycoplasma pneumoniae in the upper respiratory tract of symptomatic and asymptomatic children: an observational study. PLoS Med. 2013;10(5):e1001444. https://doi.org/10.1371/journal.pmed.1001444 PMID: 23690754
-
Jain S, Williams DJ, Arnold SR, Ampofo K, Bramley AM, Reed C, et al. . Community-acquired pneumonia requiring hospitalization among U.S. children. N Engl J Med. 2015;372(9):835-45. https://doi.org/10.1056/NEJMoa1405870 PMID: 25714161
-
Jain S, Self WH, Wunderink RG, Fakhran S, Balk R, Bramley AM, et al. . Community-acquired pneumonia requiring hospitalization among US adults. N Engl J Med. 2015;373(5):415-27. https://doi.org/10.1056/NEJMoa1500245 PMID: 26172429
Data & Media loading...
Supplementary data
-
-
Supplement
-